• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在预测慢性肾脏病预后中的应用。一项系统评价与Meta分析。

Artificial intelligence in predicting chronic kidney disease prognosis. A systematic review and meta-analysis.

作者信息

Pan Qinyu, Tong Mengli

机构信息

Hangzhou TCM Hospital, Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.

出版信息

Ren Fail. 2024 Dec;46(2):2435483. doi: 10.1080/0886022X.2024.2435483. Epub 2024 Dec 11.

DOI:10.1080/0886022X.2024.2435483
PMID:39663146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11636155/
Abstract

BACKGROUND

Chronic kidney disease (CKD) is a common condition that can lead to serious health complications. Artificial Intelligence (AI) has shown the potential to improve the prediction of CKD progression, offering increased accuracy over traditional methods. Therefore, this systematic review and meta-analysis examine the diagnostic performance of various AI models in predicting CKD.

METHOD

Search was performed in different databases for studies reporting the diagnostic accuracy of AI-based prediction models for the progression of CKD. Meanwhile, pre-defined eligibility criteria were used for the selection of studies. Pooled sensitivity, specificity, and area under curve (AUC) were calculated utilizing Meta-disc 1.4. Quality assessment was performed using the prediction model risk of bias assessment tool (PROBAST).

RESULTS

A total of 33 studies were included. The pooled sensitivity of prediction tools was 0.43 (95% CI, 0.41-0.44, = 99.3%,  < 0.01). A significant difference ( < 0.01) was also observed in the pooled specificity 0.92 (95% CI, 0.91-0.92, = 99.5%). Positive likelihood ratio (PLP) and negative likelihood ratio (NLR) were 5.12 (95% CI: 3.60-7.27, = 91.3%,  < 0.01) and 0.28 (95% CI: 0.21-0.37, = 99.3%,  < 0.01), respectively and AUC was 0.89, suggesting a diagnostic accuracy of AI-based prediction models for the progression of CKD.

CONCLUSIONS

This study demonstrates the promising potential of AI models in predicting CKD progression. However, further efforts are needed to optimize model performance, particularly in balancing sensitivity and specificity to ensure generalizability across diverse populations. Limitations of this study include the potential for overfitting in certain AI models due to imbalanced datasets. The high heterogeneity and the lack of standardized predictors limit the generalizability of findings across different populations.

摘要

背景

慢性肾脏病(CKD)是一种常见疾病,可导致严重的健康并发症。人工智能(AI)已显示出改善CKD进展预测的潜力,比传统方法具有更高的准确性。因此,本系统评价和荟萃分析考察了各种AI模型在预测CKD方面的诊断性能。

方法

在不同数据库中检索报告基于AI的CKD进展预测模型诊断准确性的研究。同时,使用预先定义的纳入标准筛选研究。利用Meta-disc 1.4计算合并敏感度、特异度和曲线下面积(AUC)。使用预测模型偏倚风险评估工具(PROBAST)进行质量评估。

结果

共纳入33项研究。预测工具的合并敏感度为0.43(95%CI,0.41 - 0.44,I² = 99.3%,P < 0.01)。合并特异度0.92(95%CI,0.91 - 0.92,I² = 99.5%)也观察到显著差异(P < 0.01)。阳性似然比(PLR)和阴性似然比(NLR)分别为5.12(95%CI:3.60 - 7.27,I² = 91.3%,P < 0.01)和0.28(95%CI:0.21 - 0.37,I² = 99.3%,P < 0.01),AUC为0.89,表明基于AI的预测模型对CKD进展具有诊断准确性。

结论

本研究证明了AI模型在预测CKD进展方面具有广阔的潜力。然而,需要进一步努力优化模型性能,特别是在平衡敏感度和特异度方面,以确保在不同人群中的可推广性。本研究的局限性包括由于数据集不平衡,某些AI模型可能存在过拟合。高度的异质性和缺乏标准化的预测指标限制了研究结果在不同人群中的可推广性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249f/11636155/4d4ecda1f58d/IRNF_A_2435483_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249f/11636155/f3f3124a0f77/IRNF_A_2435483_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249f/11636155/190872e60763/IRNF_A_2435483_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249f/11636155/5a2778bca3cb/IRNF_A_2435483_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249f/11636155/4d4ecda1f58d/IRNF_A_2435483_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249f/11636155/f3f3124a0f77/IRNF_A_2435483_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249f/11636155/190872e60763/IRNF_A_2435483_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249f/11636155/5a2778bca3cb/IRNF_A_2435483_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/249f/11636155/4d4ecda1f58d/IRNF_A_2435483_F0004_C.jpg

相似文献

1
Artificial intelligence in predicting chronic kidney disease prognosis. A systematic review and meta-analysis.人工智能在预测慢性肾脏病预后中的应用。一项系统评价与Meta分析。
Ren Fail. 2024 Dec;46(2):2435483. doi: 10.1080/0886022X.2024.2435483. Epub 2024 Dec 11.
2
Artificial intelligence for diagnosing exudative age-related macular degeneration.人工智能在渗出性年龄相关性黄斑变性诊断中的应用。
Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Metformin for preventing the progression of chronic kidney disease.二甲双胍预防慢性肾脏病进展。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013414. doi: 10.1002/14651858.CD013414.pub2.
5
Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.用于识别结直肠癌患者营养不良的营养评估工具的诊断测试准确性:一项系统综述
JBI Database System Rev Implement Rep. 2015 May 15;13(4):141-87. doi: 10.11124/jbisrir-2015-1673.
6
Artificial intelligence for detecting keratoconus.人工智能在圆锥角膜检测中的应用。
Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014911. doi: 10.1002/14651858.CD014911.pub2.
7
Artificial intelligence in the interpretation of upper extremity trauma radiographs: a systematic review and meta-analysis.人工智能在上肢创伤X线片解读中的应用:一项系统综述和荟萃分析。
JSES Rev Rep Tech. 2025 Mar 8;5(3):435-443. doi: 10.1016/j.xrrt.2025.02.004. eCollection 2025 Aug.
8
Evaluating Predictive Performance and Generalizability of Traditional and Artificial Intelligence Models in Predicting Surgical Site Infections Post-Spinal Surgery: A Systematic Review.评估传统模型和人工智能模型在预测脊柱手术后手术部位感染方面的预测性能和通用性:一项系统评价
Spine J. 2025 Jul 14. doi: 10.1016/j.spinee.2025.07.032.
9
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
10
Artificial intelligence-enabled prenatal ultrasound for the detection of fetal cardiac abnormalities: a systematic review and meta-analysis.基于人工智能的产前超声用于检测胎儿心脏异常:一项系统评价和荟萃分析。
EClinicalMedicine. 2025 May 30;84:103250. doi: 10.1016/j.eclinm.2025.103250. eCollection 2025 Jun.

引用本文的文献

1
Development and Validation of Machine Learning Models for Predicting 7-Day Mortality in Critically Ill Patients with Traumatic Spinal Cord Injury: A Multicenter Retrospective Study.用于预测创伤性脊髓损伤重症患者7天死亡率的机器学习模型的开发与验证:一项多中心回顾性研究
Neurocrit Care. 2025 Jun 25. doi: 10.1007/s12028-025-02308-y.
2
Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI.慢性肾脏病中的新兴生物标志物与先进诊断:通过多组学和人工智能实现早期检测
Diagnostics (Basel). 2025 May 13;15(10):1225. doi: 10.3390/diagnostics15101225.

本文引用的文献

1
AI-based segmentation of renal enhanced CT images for quantitative evaluate of chronic kidney disease.基于人工智能的肾脏增强 CT 图像分割用于慢性肾脏病的定量评估。
Sci Rep. 2024 Jul 23;14(1):16890. doi: 10.1038/s41598-024-67658-7.
2
Pathological mechanisms of kidney disease in ageing.衰老相关肾脏疾病的病理机制。
Nat Rev Nephrol. 2024 Sep;20(9):603-615. doi: 10.1038/s41581-024-00868-4. Epub 2024 Jul 18.
3
Predicting the Progression of Chronic Kidney Disease: A Systematic Review of Artificial Intelligence and Machine Learning Approaches.
预测慢性肾脏病的进展:人工智能和机器学习方法的系统评价
Cureus. 2024 May 12;16(5):e60145. doi: 10.7759/cureus.60145. eCollection 2024 May.
4
Management of chronic kidney disease: The current novel and forgotten therapies.慢性肾脏病的管理:当前新颖与被遗忘的疗法
J Clin Transl Endocrinol. 2024 May 22;36:100354. doi: 10.1016/j.jcte.2024.100354. eCollection 2024 Jun.
5
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial.机器学习预测慢性肾脏病进展:Klinrisk 模型在 CANVAS 项目和 CREDENCE 试验中的验证。
Diabetes Obes Metab. 2024 Aug;26(8):3371-3380. doi: 10.1111/dom.15678. Epub 2024 May 28.
6
Predicting chronic kidney disease progression with artificial intelligence.利用人工智能预测慢性肾病进展
BMC Nephrol. 2024 Apr 26;25(1):148. doi: 10.1186/s12882-024-03545-7.
7
Chronic kidney disease and the global public health agenda: an international consensus.慢性肾脏病与全球公共卫生议程:国际共识。
Nat Rev Nephrol. 2024 Jul;20(7):473-485. doi: 10.1038/s41581-024-00820-6. Epub 2024 Apr 3.
8
Temporal trends in prevalence and disability of chronic kidney disease caused by specific etiologies: an analysis of the Global Burden of Disease Study 2019.特定病因导致的慢性肾脏病患病率和残疾的时间趋势:2019 年全球疾病负担研究分析。
J Nephrol. 2024 Apr;37(3):723-737. doi: 10.1007/s40620-024-01914-x. Epub 2024 Mar 21.
9
Artificial Intelligence in Kidney Disease: A Comprehensive Study and Directions for Future Research.肾病中的人工智能:一项全面研究及未来研究方向
Diagnostics (Basel). 2024 Feb 12;14(4):397. doi: 10.3390/diagnostics14040397.
10
Investigation on explainable machine learning models to predict chronic kidney diseases.探究可解释机器学习模型在预测慢性肾脏病中的应用。
Sci Rep. 2024 Feb 14;14(1):3687. doi: 10.1038/s41598-024-54375-4.